Cargando…
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
This white paper summarizes the current consensus of the Japanese Research Working Group for the ICH S6 & Related Issues (WGS6) on strategies for the nonclinical safety assessment of oligonucleotide-based therapeutics (ONTs), specifically focused on the similarities and differences to biotechnol...
Autores principales: | Hirabayashi, Yoko, Maki, Kazushige, Kinoshita, Kiyoshi, Nakazawa, Takahiro, Obika, Satoshi, Naota, Misaki, Watanabe, Kazuto, Suzuki, Mutsumi, Arato, Teruyo, Fujisaka, Aki, Fueki, Osamu, Ito, Kosuke, Onodera, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997717/ https://www.ncbi.nlm.nih.gov/pubmed/33470890 http://dx.doi.org/10.1089/nat.2020.0879 |
Ejemplares similares
-
OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides
por: Berman, Cindy L., et al.
Publicado: (2023) -
Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND)
por: Watanabe, Atsushi, et al.
Publicado: (2017) -
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021) -
ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
por: Miranda, Claudia, et al.
Publicado: (2021)